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Abstract  
The second domain of gelsolin (G2) hosts mutations responsible for a hereditary form of 
amyloidosis. The active form of gelsolin is Ca2+-bound; it is also a dynamic protein, hence structural 
biologists often rely on the study of the isolated G2. However, the wild type G2 structure that have 
been used so far in comparative studies is bound to a crystallographic Cd2+, in lieu of the 
physiological calcium. Here, we report the wild type structure of G2 in complex with Ca2+ 
highlighting subtle ion-dependent differences. Previous findings on different G2 mutations are also 
briefly revised in light of these results. 
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Introduction 
Gelsolin (GSN) is a multifunctional Ca2+-dependent actin-binding protein, involved in the regulation 
of cytoskeleton rearrangement and cell motility by means of its severing and capping activities [1–
3]. GSN is composed of six conserved copies of a prototypical domain (named G1 to G6). Gelsolin-
like domains are characterized by a five-stranded β-sheet sandwiched between two α-helices [4,5]. 
Each GSN domain hosts at least one calcium-binding site, while only G1, G2 and G4 contains actin 
binding surfaces [4,5]. 
In Ca2+-free conditions, gelsolin adopts a compact arrangement of the six domains [2,3,5]. Upon 
calcium binding, both subtle local and large global conformational changes entail the opening of at 
least three identifiable latches (tail latch, G1–G3 latch and G4–G6 latch) to expose the actin-binding 
interfaces [2,3,5,6]. Active Ca2+-bound gelsolin is characterized by an ensemble of conformations in 
dynamic equilibrium till the adoption of a stable configuration upon binding to actin [4,5,7,8]. As a 
consequence, the crystal structure of Ca2+-bound actin-free gelsolin has never been obtained and 
isolated domains have become the focus of several structural studies.  
Among the six gelsolin domains, G2 has been characterized the most [9–16], because four mutations 
in this domain (D187N, D187Y, G167R and N184K; according to the numbering of the mature plasma 
protein) have been described to be responsible for a rare genetic disease named AGel amyloidosis 
[17–20]. AGel amyloidosis is an autosomal-dominant monogenic disease. Symptoms include corneal 
lattice dystrophy, cranial neuropathy, skin elasticity problems, and renal complications [21–23]. 
The G2-related mutations occur at different sites: D187 is part of the Ca2+-binding site, both N and 
Y substitutions impair the ion binding [9,11–16]; the N184K mutant is still able to bind calcium and 
the geometry of the binding site matches that of wild type (WT) protein [10]; the G167R mutation 
was shown to promote the dimerization of GSN via a peculiar 3D domain swap mechanism [9]. 
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Irrespective of the underlying mechanism, all the mutations so far characterized cause a drop in the 
thermodynamic stability of the isolated domain and increase its conformational flexibility [9–16]. 
As a consequence, mutated G2 becomes protease-sensitive and, in the Golgi, it is readily processed 
by furin, producing 8- and 5-kDa amyloidogenic peptides which self-assemble [14,24,25]. In 2018, 
four novel gelsolin pathogenic variants were described [26–29], which carry the mutation in other 
domains, either G4 or G5, and a N-terminal frame-shift. 
Over the years, the superimposition of the structures of the mutated G2 domains on the WT 
structure has been critical in understanding the conformational changes and the destabilization 
caused by the mutations. The reference structure used so far hosts a crystallographic Cd2+ in the 
Ca2+ binding site instead of the physiological ion [12]. During the transition from the closed to the 
open conformation in WT and mutated proteins, Ca2+ plays a crucial role. Cd2+ and Ca2+ have similar 
ionic radii (0.97 Å and 0.99 Å, respectively), however, gelsolin G2 octa-coordinates Ca2+, while the 
only Cd2+-dependent protein reported so far, carbonic anhydrase of marine diatoms, show penta-
coordination [30]. In most of the organisms, these enzymes bind Zn2+ and substitution of the ion 
was shown to impact the geometry of the metal binding site as well as the catalytic efficiency. 
Here, we report four novel high-resolution structures of the isolated WT G2 bound to the 
physiological ion. Among these, the best-diffracting data is proposed as a new model for the WT 
protein, and differences between WT and pathological mutants are briefly reviewed in light of this 
result. 
 
 
Materials and methods 
Protein production 
5 
 
The isolated WT G2 domain (residues 151-262) was produced in E. coli cells and purified as 
previously described [9–11].  
 
 
Crystallization, structure solution and analysis 
WT G2 concentrated to 900 𝜇M in 20 mM HEPES, pH 7.4, 100 mM NaCl and 1 mM CaCl2 was used 
in extensive crystallization trials using an Oryx-4 robot (Douglas Instrument) and sitting-drop plates. 
Several different commercial screen solutions were tested, varying the protein:precipitant ratio (0.4 𝜇l total drop volume) and the plates were stored at 20°C. Crystals of the G2 domain readily appeared 
in the conditions reported in Table 1, they were cryoprotected in a reservoir solution supplemented 
with 20% glycerol and then flash-cooled in liquid nitrogen. 
X-ray diffraction data were collected at beamline I04 (Diamond Light Source, Oxfordshire) at 100°K. 
Data were processed using XDS [31] or DIALS [32] and scaled with AIMLESS [33]. WT G2 crystal 
structures were solved by molecular replacement with PHASER [34] using the G2 WT structure (PDB 
ID 1KCQ [12]) as a search model. Phenix refine [35] was used for the refinement of the structures 
while manual model building was performed with Coot [36]. All the structures reported in this 
manuscript were refined to commonly accepted values (see Table 1 for a complete list of data and 
model statistics). However, only the best-diffracting structure was deposited in the PDB with 
accession code 6QW3, to be proposed as the new reference model for future comparative studies.  
Analysis of the structures was performed with PyMOL (Schrödinger; DeLano, 2002), which was also 
used to prepare the figures. Global RMSD and per residue analysis were performed with Prosmart 
[37]. 
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Results and Discussion 
The structure of Ca2+-bound WT G2 
Owing to the difficulties associated to the study of active GSN, different constructs of the isolated 
G2 domain have been extensively studied and its high-resolution crystal structure solved in 2002 
[12]. This relevant finding allowed the identification of the metal binding site and set the bases to 
dissect the pathological mechanism underlying the D187N/Y-dependent amyloidosis. Since its 
publication, this structural model has been used as a reference to compare the pathological variants 
and infer the impact of the mutations on the structure of the isolated G2. However, the crystal was 
obtained in the presence of high concentration of cadmium chloride and Cd2+ was modelled in the 
metal binding site, instead of the physiological Ca2+.  
With the exception of G167R dimer, all the mutated G2 domains analysed so far show subtle 
differences compared with the WT protein. Therefore, an accurate reference model is required. In 
this context, extensive crystallization trials of the WT G2 in the presence of saturating Ca2+ 
concentrations have been performed. Crystals readily appeared in several conditions yielding four 
well-diffracting (1.3-1.5 Å resolution) different crystalline forms. Table 1 shows a complete list of 
data collection and refinement statistics. 
Dataset 1KCQ 6QW3 MP MC O 6RLK 
Space group monoclinic 
C 2 
orthorhombic 
P 2 21 21 
monoclinic 
primitive 
P 2 
monoclinic 
centered 
I 2 
orthorhombic 
P 2 21 21 
Bound ion Cd2+ Ca2+ Ca2+ Ca2+ Ca2+ 
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Crystallization 
Conditions 
20% PEG 400, 50 
mM cadmium 
chloride, 100 mM 
sodium acetate, pH 
4.6 
36% PEG 5k MME, 
0.1M sodium 
acetate, pH 5.5 
40% PEG 500 MME, 
20% PEG 20k, 1.0M 
Imidazole/MES , pH 
6.5 
30% PEG 4k, 0.2M 
Imidazole Malate, 
pH 6.0 
24% PEG 8k, 5 mM 
zinc acetate, 0.1M 
sodium 
cacodylate, pH 6.5 
Data collection 
Wavelength (Å) 1.20 0.98 0.98 0.98 0.98 
Cell dimensions 
a, b, c; 
α, β, γ (Å;°) 
97, 27, 50;  
90, 121, 90 
27, 50, 71;  
90, 90, 90 
50, 27, 51;  
90, 118, 90 
50, 27, 86;  
90, 92, 90 
27, 50, 81; 
90, 90, 90 
Unique 
reflections 
14,799 24,096 23,133 20,405 17,949 
Resolution 
range (Å) 
43.03-1.65 
(1.74-1.65) 
70.82-1.30 
(1.32-1.30) 
44.97-1.40 
(1.42-1.40) 
42.82-1.45 
(1.47-1.45) 
18.95-1.50 
(1.54-1.50) 
I/σ(I) (3.3) 
 
14.0 (1.8) 16.1 (7.2) 5.7 (0.8) 6.5 (0.9) 
CC 1/2  1.00 (0.58) 1.00 (0.96) 1.00 (0.59) 0.99 (0.29) 
Completeness 
(%) 
99.2 99.5 (92.9) 97.0 (93.4) 99.9 (99.6) 99.8 (99.9) 
Multiplicity 3.3 (2.7) 10.8 (4.3) 6.5 (5.1) 6.5 (5.4) 10.4 (8.7) 
Refinement      
Resolution 
range (Å) 
22.25-1.65 41-1.30 44.97-1.40 42.25-1.45 18.95-1.50 
Rwork/Rfree* 0.177/0.233 0.154/0.174 0.137/0.178 0.177/0.219 0.204/0.241 
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RMSD 
Bonds/angles 
(Å/°) 
0.007/1.900 0.016/1.469 0.016/1.324 0.006/0.856 0.015/1.902 
Ramachandran 
outliers (%) 
0 0 0 0 0.8 
B factors (Å2)§ 22 21 19 28 23 
 
Table 1: Data collection and refinement statistics of WT G2s bound to Ca2+. * Rwork = Σhkl||Fo| − 
|Fc|| / Σhkl|Fo| for all data, except 5-10%, which were used for Rfree calculation. § Average 
temperature factors over the whole structure. 
 
One of these crystals (O) grew in 5 mM zinc acetate; however, no anomalous signal was detected, 
confirming the presence of Ca2+ in the metal binding site. All four models should be considered 
equally representative of WT Ca2+-bound G2. Comparison of these models facilitates the 
identification of structural differences caused by the crystalline packing or by some intrinsic 
flexibility of specific stretches of the protein. Overall the four structures superimpose particularly 
well (Figure 1A and Table 2) and minor deviations of the backbone are observed only in the loop 
connecting β5 to α2 (residues 236-240). Owing to the quality of the data, one of the two 
orthorhombic crystals was deposited in the PDB with accession code 6QW3 and represents the 
reference structure chosen for the comparison of the WT G2 Ca2+-bound form with the Cd2+-bound 
form (Figure 1B). 6QW3 was subjected to the RMSD per residue analysis versus all the others WT 
G2-Ca2+ complex structures; the values were averaged to calculate an unbiased value (i.e. a value 
independent of crystal packing) that was subtracted from the RMSD of 6QW3 Vs. 1KCQ (Figure 1C). 
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This analysis should specifically mark differences due to the nature of the bound ion. Indeed, only 
two regions of G2 show significant differences in RMSD values: i) the hinge loop (hosting the furin 
aberrant cleavage site, residues 168 and 169) and ii) the C-terminal tail of the domain (residues 255-
260).  
Differences in the hinge loop might be due to mis-modelling of a noisy area of the structure (Figure 
3). Contrarily, the electron density of the C-terminus is of sufficient quality to take into consideration 
a proper conformational change (Figure 2). In addition to the opportunistic ion, three additional 
Cd2+ were modelled in the 1KCQ asymmetric unit. One of these Cd2+ is relevant for our analysis as it 
is coordinated by the C-terminal residue E258, less than 6 Å afar from the physiological metal site 
(Figure 2). It is difficult to determine the impact of this Cd2+ on the structure of the G2, because it 
sits near a crystallographic two fold axis (0.4 Å) and it has been refined to 0.5 occupancy. However, 
we cannot exclude that this second Cd2+ contributes to the subtle differences observed in the C-
terminal region. 
We can conclude that, to allocate the Cd2+ ion in the metal binding site, the C-terminal tail 
undergoes subtle but significant rearrangements. These adjustment of the backbone are related to 
an increased flexibility of the hinge loop.  
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Figure 1: Ion-dependent differences in the WT G2. A) Cα-traces of the 4 aligned structures of G2 WT 
bound to Ca2+ (6QW3 in orange, MP in cyan, MC in green and O in white). B) Cα-traces of Ca2+-bound 
6QW3 (in orange) superimposed on the Cd2+-bound 1KCQ (in grey) C) “Net” RMSD values of 6QW3 
Vs. 1KCQ (Å) (i.e. RMSD subtracted from average RMSD Vs. other Ca2+-bound structures). 
 
  6QW3 MP MC O 
1KCQ 0.537 0.551 0.493 0.611 
6QW3   0.461 0.260 0.423 
MP     0.295 0.347 
MC       0.287 
 
Table 2: Ion-dependent differences in the WT G2. Multiple alignment scores were obtained from 
ProSMART (RMSD values, Å); residues 159-260 (102 Cα atoms) were used in this analysis. 
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Figure 2: Details of the metal binding site in the WT G2 structure. Left: sticks model of WT G2 
(orange) bound to Ca2+ (green sphere). Right: 1KCQ (grey), bound to Cd2+ (yellow). Electron density 
is contoured at 1.5 σ. 
 
Structural differences between Ca2+-bound WT and mutated G2 
Different arrangements of the C-terminal tail are observed in most of the G2 domain pathological 
variants. Two crystal structures of N184K variant were obtained and in one of the resulting models 
the terminal tail was fully displaced, leaving the calcium binding pocket exposed to solvent [10]. 
Although this conformation was partly due to the stabilization induced by the crystal packing, this 
behavior might result from the increased flexibility of the C-terminus. In the G167R variant, which 
has been crystallized only in the domain-swapped conformation, the terminal tail is displaced, with 
the metal binding site accessible to the solvent and a citrate molecule completing the coordination 
of the ion [9]. The structure of the D187N variant, although obtained as a complex with a stabilizing 
nanobody, showed a very flexible C-terminus that could only be modelled to a limited extent [11].  
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In conclusion, in all the variants structurally characterized so far, major differences have been 
observed between WT and mutants' C-terminal dynamics. The subtle differences observed between 
the Ca2+- and Cd2+-bound WT are not functionally significant. Moreover, the study of the mechanism 
of action of the chaperoning nanobody revealed that the destabilization of the C-terminal tail is not 
a major determinant of mutated gelsolin susceptibility to aberrant proteolysis [11]. In fact, the 
nanobody is able to restore thermodynamic stability of mutated G2 without recovering the native 
conformation of the C-terminus. 
 
The impact of the pathological mutations may have been so far underestimated because the same 
region in the WT protein has been considered intrinsically flexible. Cd2+ binding instead of the 
physiological ion leads to a destabilization of the hinge loop, in particular of residues 168 and 169, 
which becomes poorly resolved (Figure 3). Low quality of the electron density was observed in other 
destabilized conformation of the protein, such as the N184K variant which, despite the atomic 
resolution shows poorly resolved residues 168 and 169 (Figure 3).  
Contrary, in the stable or stabilized (by nanobody) variants, the residues belonging to the loop could 
be unambiguously traced, as it is the case of D187N and G167R. This observation unravels some 
controversies between previously reported experimental and computational data. MD simulations 
have been extensively used to characterise the dynamic behaviour of gelsolin mutants and often 
highlighted an increased flexibility of the hinge loop in the destabilized mutants. D187N showed 
significant differences with respect to the WT when the simulation-derived B-factors were 
compared [11,12]. Similar results were reported for MD simulations on the monomeric form of the 
G167R variant [9]. 
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In conclusion, our results on G2 WT in complex with Ca2+ demonstrate that the increased flexibility 
of the hinge loop is a major determinant of mutated G2 instability. The aberrant cleavage of the 
hinge loop by furin is the first step of the pathological pathway which leads to mutated gelsolin 
deposition. In previous studies, pathogenic mutations have been described as responsible for the 
exposure of the furin recognition site. However, in the open conformation of gelsolin, the hinge loop 
is likely solvent accessible. We already showed that the C-terminus of G2 provides only a minor 
steric protection, i.e. its destabilization is required but not sufficient [10,11]. A rearrangement of 
the hinge loop is therefore likely needed to fit into the active site of the protease that has been 
shown to recognize rather stretched peptides [38,39]. 
 
Figure 3: Impact of ions and mutations on the conformation and flexibility of the hinge loop. Close-
view of the hinge loop (residues 166 to 172) in the available G2 structures: WT in complex with Ca2+ 
(WT+Ca2+, PDB ID 6QW3, this work) or with Cd2+ (WT+Cd2+, PDB ID 1KCQ [12]), D187N in complex 
with the chaperone nanobody (D187N Nb-stabilized, PDB ID 6H1F [11]), N184K in complex with Ca2+ 
(N184K+Ca2+, PDB ID 5FAF [10]) and G167R in the domain-swapped dimeric form bound to Ca2+ 
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(G167R+Ca2+, PDB ID 5O2Z [9]). residues are represented as sticks and electron density displayed at 
1.5 σ.  
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